Late Breaking News
Flu Research Sparks Debate About Bioterrorism and Government Control Cont.
Balancing Scientific Freedom
The controversy is not unexpected. Fouchier announced the contents of his research at a conference on influenza research in Malta in September.
Since then, scientists around the world have been ramping up the debate about how to balance scientific freedom and public safety when it comes to “dual-use research” — research that has the potential to be misused to threaten public health or national security.
A similar discussion arose in 2005 when researchers replicated the flu strain that led to the 1918 Spanish Flu epidemic, which killed at least 3% of the world’s population. However, that research was eventually published in full.
In this case, some scientists and media opinion pieces are saying the research should never have been attempted in the first place, going so far as to compare such research to the kind attempted by comic book super-villains. Others have swung to the opposite pole, stating that any attempt by the federal government to curtail scientific discourse is a slippery slope that could lead to the stifling of innovation.
Fouchier and Kawaoka, along with the editors of Science and Nature, have tentatively agreed to go along with NSABB’s nonbinding recommendation that they omit key details of their research, with conditions, such as the creation of a method by which scientists can have free and transparent access to the information for research purposes. According to the researchers and the journal’s editors, access to that information could help speed development of new treatments to combat the virus.
“Many scientists within the influenza community have a bona fide need to know the details of this research in order to protect the public, especially if they currently are working with related strains of the virus,” said Science editor-in-chief Bruce Albert in a statement. “Science editors will be evaluating how best to proceed. Our response will be heavily dependent upon the further steps taken by the U.S. government to set forth a written, transparent plan to ensure that any information that is omitted from the publication will be provided to all those responsible scientists who request it.”
What that transparent system will look like is under discussion.
In the meantime, a group of influenza researchers, including Fouchier and Kawaoka, have written a statement published January 20in Science and Nature declaring a 60-day moratorium on any research into H5N1 that could lead to the virus becoming more transmissible to humans.
According to the scientists, the moratorium is to allow time for the scientific community to have a discussion, among itself and with the public, about the safety and benefits of H5N1 research. In the statement, the researchers said that they recognize that the scientific community, organizations, and governments need time to discuss the opportunities and challenges stemming from the research, and that they hope to do so in an international forum.
That forum could be hosted by the World Health Organization, although nothing has yet been added to that group’s calendar.
The topic is expected to be discussed at the American Society for Microbiology’s annual Biodefense and Emerging Diseases Research meeting in Washinton this month, however. A number of health leaders, including NIAID’s director Anthony Fauci, MD, will likely discuss the NSABB recommendations and how they impact federal policy issues.
Related Infectious Disease Articles
- TRICARE Faces Challenges in Getting Males to Complete Three-Shot HPV Vaccine Series
- Rabies Exposure Reports Skyrocket in Theater After Army Cracks Down on Pets
- Rates of Meningococcal Disease in Military Plummet
- Right Amount of Information Affects Vaccine Rates
- Flu Vaccines Equally Effective in Military Population
- Drug Approved to Boost Platelet Counts Could Increase VA HCV Treatment Rates
- Legionnaires' Disease Kills Patient at Pittsburgh VAMC
- Longer Treatment of Male UTI Doesn't Decrease Recurrence Rates
- HIV Patients Appear to Age More Rapidly; Researchers Want to Know Why That Is
- VA Seeks to Increase Low Hepatitis C Treatment Rate for HIV Positive Patients